{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:07:17Z","timestamp":1761919637102},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jocn.2012.06.006","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T05:31:08Z","timestamp":1352439068000},"page":"94-98","source":"Crossref","is-referenced-by-count":27,"title":["The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica"],"prefix":"10.1016","volume":"20","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2012.06.006_b0005","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2012.06.006_b0010","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00415-006-0400-z","article-title":"Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features","volume":"254","author":"Nakashima","year":"2007","journal-title":"J Neurol."},{"key":"10.1016\/j.jocn.2012.06.006_b0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/1352458507087844","article-title":"Clinical features of patients with multiple sclerosis from a survey in Shanghai, China","volume":"14","author":"Cheng","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2012.06.006_b0020","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2012.06.006_b0025","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/archneur.63.10.1398","article-title":"Neuromyelitis optica IgG status in acute partial transverse myelitis","volume":"63","author":"Scott","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2012.06.006_b0030","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.06.006_b0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1590\/S0004-282X2008000100034","article-title":"Devic\u2019s neuromyelitis optica: a critical review","volume":"66","author":"Lana-Peixoto","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jocn.2012.06.006_b0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.06.006_b0045","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.06.006_b0050","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2012.06.006_b0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1017\/S0317167100013287","article-title":"Serum-positive and negative AQP4 antibody NMO in Chinese patients","volume":"39","author":"Long","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jocn.2012.06.006_b0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2012.06.006_b0065","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.06.006_b0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1212\/01.WNL.0000101715.32569.1A","article-title":"Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies","volume":"62","author":"Hummers","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.06.006_b0075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jocn.2012.06.006_b0080","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.06.006_b0085","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/brain\/awm027","article-title":"Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese","volume":"130","author":"Matsuoka","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2012.06.006_b0090","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/jnnp.2005.080390","article-title":"Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG","volume":"77","author":"Nakashima","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.06.006_b0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1196\/annals.1444.002","article-title":"Neuromyelitis optica and asian phenotype of multiple sclerosis","volume":"1142","author":"Kira","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jocn.2012.06.006_b0100","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devic\u2019s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.06.006_b0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000250927.21903.f8","article-title":"Diagnosis and treatment of neuromyelitis optica","volume":"13","author":"Wingerchuk","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.jocn.2012.06.006_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2006.10.008","article-title":"Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination","volume":"252","author":"Warabi","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2012.06.006_b0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1352458506070732","article-title":"Immunosuppressive therapy is more effective than interferon in neuromyelitis optica","volume":"13","author":"Papeix","year":"2007","journal-title":"Mult Scler"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586812003487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586812003487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T15:21:29Z","timestamp":1540135289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586812003487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0967586812003487"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2012.06.006","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}